Lorusso Roberto, Alexander Peta, Rycus Peter, Barbaro Ryan
Cardio-Thoracic Surgery Department, Heart & Vascular Centre, Maastricht University Medical Centre, Maastricht, The Netherlands.
Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts, USA.
Ann Cardiothorac Surg. 2019 Jan;8(1):93-98. doi: 10.21037/acs.2018.11.03.
From the birth of the Extracorporeal Life Support Organization (ELSO) Registry in 1989, collecting the most relevant information about extracorporeal life support (ECLS) for refractory cardiac or respiratory compromise, was created in order to provide useful information and benchmark for ECLS users. Throughout the years, the Registry has continuously developed, achieving in 2018 more than 100,000 patients included with almost 500 ELSO centers around the world. Based on the relevance and impact of database analysis, and due to the growing need for more advanced and high-quality clinical investigations, the ELSO Registry is under substantial re-engineering which will allow and provide the ELSO members and the scientific community an enhanced scientific tool to elucidate various aspects of the ECLS settings, including trends and disease-specific information, to perform benchmarking about our own results and outcomes as compared to regional or worldwide results, and to provide an invaluable source of data for clinical investigations.
自体外生命支持组织(ELSO)注册中心于1989年成立以来,一直在收集有关难治性心脏或呼吸功能不全的体外生命支持(ECLS)的最相关信息,目的是为ECLS使用者提供有用信息和基准。多年来,该注册中心不断发展,在2018年已有来自全球近500个ELSO中心的超过100,000名患者纳入其中。基于数据库分析的相关性和影响力,以及对更先进和高质量临床研究的需求不断增加,ELSO注册中心正在进行重大的重新设计,这将为ELSO成员和科学界提供一个增强的科学工具,以阐明ECLS设置的各个方面,包括趋势和特定疾病信息,将我们自己的结果与区域或全球结果进行比较以进行基准测试,并为临床研究提供宝贵的数据源。